1. Volume 12, Issue 6, Pages 539-545 (June 2013)
Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials 
Dr William N Whiteley, PhD, Harold P Adams, MD, Philip MW Bath, FRCP, Eivind Berge, MD, Per Morten Sandset, MD, Martin Dennis, MD, Gordon D Murray, PhD, Ka-Sing Lawrence Wong, MD, Peter AG Sandercock, MD 
The Lancet Neurology 
Volume 12, Issue 6, Pages (June 2013)
DOI: /S (13)
Copyright © 2013 Elsevier Ltd Terms and Conditions

2. Figure 1
Association of baseline variables with thrombotic events—myocardial infarction, recurrent ischaemic stroke, deep vein thrombosis, and pulmonary embolism
Each square represents the point estimate from a random effects meta-analysis across trials, and the horizontal line the 95% CI. N=number of patients. n=number of events in each meta-analysis. NIHSS=National Institutes of Health stroke scale.
The Lancet Neurology  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions

3. Figure 2
Association of baseline variables with haemorrhagic events (intracranial or extracranial haemorrhage)
Each square represents the point estimate from a random effects meta-analysis across trials, and the horizontal line the 95% CI. N=number of patients, n=number of events in each meta-analysis.
The Lancet Neurology  , DOI: ( /S (13) )
Copyright © 2013 Elsevier Ltd Terms and Conditions